Viewing Study NCT00174395


Ignite Creation Date: 2025-12-24 @ 1:35 PM
Ignite Modification Date: 2026-01-24 @ 5:19 AM
Study NCT ID: NCT00174395
Status: COMPLETED
Last Update Posted: 2021-01-27
First Post: 2005-09-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A1601107
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators